HeartWare (HTWR +5.5%) beating strongly after the FDA says the firm's blood pump appears to aid...
HeartWare (HTWR +5.5%) beating strongly after the FDA says the firm's blood pump appears to aid patients with severe heart failure. However, the agency raises safety concerns about clotting rates and stroke, and says the clinical trials may have missing data and are difficult to compare. An FDA advisory panel is due to vote on the device on Wednesday.
From other sites
at CNBC.com (Mar 13, 2013)
at CNBC.com (Jun 17, 2011)
at CNBC.com (Mar 18, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs